chrX-129920561-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000394422.8(UTP14A):āc.857T>Cā(p.Ile286Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000289 in 1,209,886 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 15 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000018 ( 0 hom., 1 hem., cov: 23)
Exomes š: 0.000030 ( 0 hom. 14 hem. )
Consequence
UTP14A
ENST00000394422.8 missense
ENST00000394422.8 missense
Scores
1
3
13
Clinical Significance
Conservation
PhyloP100: 5.95
Genes affected
UTP14A (HGNC:10665): (UTP14A small subunit processome component) This gene encodes a member of the uridine triphosphate 14 family. As an essential component of a large ribonucleoprotein complex bound to the U3 small nucleolar RNA, the encoded protein is involved in ribosome biogenesis and 18S rRNA synthesis. An autosomal retrotransposed copy of this X-linked gene exists on chromosome 13. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.21079609).
BS2
High Hemizygotes in GnomAdExome4 at 14 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UTP14A | NM_006649.4 | c.857T>C | p.Ile286Thr | missense_variant | 9/15 | ENST00000394422.8 | NP_006640.2 | |
LOC105373335 | XR_007068332.1 | n.1773+9197A>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UTP14A | ENST00000394422.8 | c.857T>C | p.Ile286Thr | missense_variant | 9/15 | 1 | NM_006649.4 | ENSP00000377944 | P1 | |
ENST00000432062.1 | n.206+9197A>G | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111633Hom.: 0 Cov.: 23 AF XY: 0.0000295 AC XY: 1AN XY: 33873
GnomAD3 genomes
AF:
AC:
2
AN:
111633
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
33873
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000163 AC: 3AN: 183510Hom.: 0 AF XY: 0.0000294 AC XY: 2AN XY: 67942
GnomAD3 exomes
AF:
AC:
3
AN:
183510
Hom.:
AF XY:
AC XY:
2
AN XY:
67942
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000300 AC: 33AN: 1098253Hom.: 0 Cov.: 31 AF XY: 0.0000385 AC XY: 14AN XY: 363607
GnomAD4 exome
AF:
AC:
33
AN:
1098253
Hom.:
Cov.:
31
AF XY:
AC XY:
14
AN XY:
363607
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111633Hom.: 0 Cov.: 23 AF XY: 0.0000295 AC XY: 1AN XY: 33873
GnomAD4 genome
AF:
AC:
2
AN:
111633
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
33873
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ExAC
AF:
AC:
3
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 05, 2022 | The c.857T>C (p.I286T) alteration is located in exon 9 (coding exon 9) of the UTP14A gene. This alteration results from a T to C substitution at nucleotide position 857, causing the isoleucine (I) at amino acid position 286 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Benign
T
PROVEAN
Uncertain
N;N;D
REVEL
Benign
Sift
Benign
D;D;T
Sift4G
Benign
T;T;T
Polyphen
0.0040
.;B;.
Vest4
MutPred
0.47
.;Loss of stability (P = 0.0289);.;
MVP
MPC
0.36
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at